Pricing Log in Create free account

Brainsway Ltd. Sponsored ADR (BWAY) vs Sight Sciences, Inc. (SGHT)

Brainsway Ltd. Sponsored ADR and Sight Sciences, Inc. are both Medical Devices companies. Brainsway Ltd. Sponsored ADR and Sight Sciences, Inc. are of similar size ($484.8M and $475.8M). Sight Sciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Brainsway Ltd. Sponsored ADR trades at 24.8×. Brainsway Ltd. Sponsored ADR grew revenue faster over the last twelve months: 31.7% against 9.27%. Brainsway Ltd. Sponsored ADR has the higher net margin (15.6% vs −35.7%) and the higher return on invested capital (30.0% vs −125.2%). Across the 18 metrics below, Brainsway Ltd. Sponsored ADR leads on 15 and Sight Sciences, Inc. on 3.

Valuation

Metric BWAY SGHT Medical Devices median
P/E 24.80 n/m 23.22
P/S 3.64 5.41 2.34
P/B 2.79 8.53 2.33
Price to free cash flow 38.17 n/m 23.72
EV/EBITDA 17.37 n/m 11.54
EV/Sales 2.64 4.95 2.24
Earnings yield 4.03% (6.76%) (10.09%)
Free cash flow yield 2.62% (5.17%) (8.47%)

Profitability

Metric BWAY SGHT Medical Devices median
Gross margin 75.32% 87.96% 56.01%
Operating margin 12.46% (33.43%) (15.03%)
Net margin 15.55% (35.69%) (20.40%)
Free cash flow margin 9.53% (27.98%) (7.24%)
Return on equity 12.82% (48.42%) (15.32%)
Return on assets 8.09% (26.24%) (19.72%)
Return on invested capital 29.98% (125.18%) (10.33%)

Growth

Metric BWAY SGHT Medical Devices median
Revenue growth (TTM) 31.71% 9.27% 8.80%
EPS growth (last fiscal year) 114.29% 28.16% 29.03%
Revenue growth, 5-year CAGR 18.81% 22.86% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BWAY SGHT Medical Devices median
Debt to equity 0.00 0.77 0.07
Current ratio 3.59 4.95 2.50
Net debt to EBITDA (11.84) 1.45 0.49

Dividend

Metric BWAY SGHT Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric BWAY SGHT Medical Devices median
Market cap 475.75m 484.78m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack